151 related articles for article (PubMed ID: 36992732)
21. Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes.
Koch KL; Hasler WL; Yates KP; Parkman HP; Pasricha PJ; Calles-Escandon J; Snape WJ; Abell TL; McCallum RW; Nguyen LA; Sarosiek I; Farrugia G; Tonascia J; Lee L; Miriel L; Hamilton F;
Neurogastroenterol Motil; 2016 Jul; 28(7):1001-15. PubMed ID: 26946489
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of Insulin Degludec in Thai Patients with Diabetes Mellitus: Real-World Evidence From a Specialized Diabetes Center.
Thewjitcharoen Y; Yenseung N; Malidaeng A; Butadej S; Chotwanvirat P; Krittiyawong S; Thammawiwat C; Himathongkam T
Exp Clin Endocrinol Diabetes; 2021 Sep; 129(9):666-673. PubMed ID: 31597169
[TBL] [Abstract][Full Text] [Related]
23. Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types - A prospective, matched control study.
Tittel SR; Laubner K; Schmid SM; Kress S; Merger S; Karges W; Wosch FJ; Altmeier M; Pavel M; Holl RW;
J Diabetes; 2021 Dec; 13(12):1007-1014. PubMed ID: 34275207
[TBL] [Abstract][Full Text] [Related]
24. Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus.
Shafie AA; Ng CH; Tan YP; Chaiyakunapruk N
Pharmacoeconomics; 2017 Feb; 35(2):141-162. PubMed ID: 27752998
[TBL] [Abstract][Full Text] [Related]
25. Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis.
Melo KFS; Bahia LR; Pasinato B; Porfirio GJM; Martimbianco AL; Riera R; Calliari LEP; Minicucci WJ; Turatti LAA; Pedrosa HC; Schaan BD
Diabetol Metab Syndr; 2019; 11():2. PubMed ID: 30622653
[TBL] [Abstract][Full Text] [Related]
26. Switching from Neutral Protamine Hagedorn Insulin to Insulin Glargine 300 U/mL Improves Glycaemic Control and Reduces Hypoglycaemia Risk: Results of a Multicentre, Prospective, Observational Study.
Wolnik B; Wiza D; Szczepanik T; Syta A; Klupa T
J Diabetes Res; 2020; 2020():8751348. PubMed ID: 32337298
[TBL] [Abstract][Full Text] [Related]
27. Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study.
Zaccardi F; Rocca B; Rizzi A; Ciminello A; Teofili L; Ghirlanda G; De Stefano V; Pitocco D
Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):902-909. PubMed ID: 28838851
[TBL] [Abstract][Full Text] [Related]
28. Is insulin the preferred treatment for HbA1c >9%?
Bloomgarden Z
J Diabetes; 2017 Sep; 9(9):814-816. PubMed ID: 28589542
[TBL] [Abstract][Full Text] [Related]
29. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
[TBL] [Abstract][Full Text] [Related]
30. Reduced Rates of Hypoglycemia in Type 1 or Type 2 Diabetes After Switching to Insulin Degludec: Results from the Italian Cohort of the ReFLeCT Study.
Fadini GP; Giordano C; Salvi L; Nicolucci A;
Diabetes Ther; 2020 Dec; 11(12):2909-2920. PubMed ID: 33011923
[TBL] [Abstract][Full Text] [Related]
31. Influence of baseline glycemia on outcomes with insulin glargine use in patients uncontrolled on oral agents.
Banerji MA; Baron MA; Gao L; Blonde L
Postgrad Med; 2014 May; 126(3):111-25. PubMed ID: 24918797
[TBL] [Abstract][Full Text] [Related]
32. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
33. Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study.
Greven WL; Beulens JW; Biesma DH; Faiz S; de Valk HW
Diabetes Technol Ther; 2010 Sep; 12(9):695-9. PubMed ID: 20687867
[TBL] [Abstract][Full Text] [Related]
34. Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM.
Osaki A; Shimoda Y; Okada J; Yamada E; Saito T; Nakajima Y; Ozawa A; Niijima Y; Okada S; Yamada M
Diabetes Ther; 2019 Aug; 10(4):1531-1534. PubMed ID: 31197753
[TBL] [Abstract][Full Text] [Related]
35. Can an electronic glycaemic notebook associated with an insulin calculator improve HbA1c in diabetic patients on a multiple insulin injections regimen? A 26-week observational real-life study.
Oriot P; Ponchon M; Hermans MP
Acta Clin Belg; 2016 Feb; 71(1):51-6. PubMed ID: 27150670
[TBL] [Abstract][Full Text] [Related]
36. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
37. Short and long-term metabolic outcomes in patients with type 1 and type 2 diabetes receiving a simultaneous pancreas kidney allograft.
Hau HM; Jahn N; Brunotte M; Lederer AA; Sucher E; Rasche FM; Seehofer D; Sucher R
BMC Endocr Disord; 2020 Feb; 20(1):30. PubMed ID: 32106853
[TBL] [Abstract][Full Text] [Related]
38. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
[TBL] [Abstract][Full Text] [Related]
39. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
[TBL] [Abstract][Full Text] [Related]
40. Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis.
Guillermin AL; Samyshkin Y; Wright D; Nguyen T; Villeneuve J
J Med Econ; 2011; 14(2):207-16. PubMed ID: 21361858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
